Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IRB Costs Would Be Recoupable As Direct Costs Under Sen. Kennedy Bill

This article was originally published in The Gray Sheet

Executive Summary

Institutional review board operational expenses could be billed as direct costs on federal grants, ensuring the review bodies receive adequate resources under legislation introduced by Sen. Edward Kennedy (D-Mass.) Oct. 4

You may also be interested in...



PoC Test R&D Complicated By Emergency Consent Provisions – Genzyme Rep

FDA emergency research regulations requiring a therapeutic window to obtain informed consent may slow down development of rapid diagnostics for stroke and heart attack, according to Genzyme VP-Regulatory Affairs Robert Yocher

GOP Sens. Frist, Santorum Set To Join Finance Committee In 108th Congress

The appointment of Sen. Bill Frist (R-Tenn.) to the Senate Finance Committee in the 108th Congress may help improve the reimbursement climate for innovative medical technologies

PoC Test R&D Complicated By Emergency Consent Provisions – Genzyme Rep

FDA emergency research regulations requiring a therapeutic window to obtain informed consent may slow down development of rapid diagnostics for stroke and heart attack, according to Genzyme VP-Regulatory Affairs Robert Yocher

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel